Daniel Pinto

Dr. Daniel Pinto


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
PMPedro Henrique Q. S. De Medeiros
Pedro Henrique Q. S. De Medeiros
DPDaniel Pinto
Daniel Pinto
JAJuliana Zani De Almeida
Juliana Zani De Almeida
JRJuliana M. C. Rêgo
Juliana M. C. Rêgo
FRFrancisco A. P. Rodrigues
Francisco A. P. Rodrigues
ROReinaldo Oria
Reinaldo Oria
The micronutrient vitamin A refers to a group of compounds with pleiotropic effects on human health. These molecules can modulate biological functions, including development, vision, and regulation of the intestinal barrier. The consequences of vitamin A deficiency and supplementation in children from developing countries have been explored for several years. These children live in an environment that is highly contaminated by enteropathogens, which can, in turn, influence vitamin A status. Vitamin A has been described to modulate gene expression, differentiation and function of diverse immune cells; however, the underlying mechanisms are not fully elucidated. This review aims to summarize the most updated advances on elucidating the vitamin A effects targeting intestinal immune and barrier functions, which may help in further understanding the burdens of malnutrition and enteric infections in children. Specifically, by covering both clinical and in vivo/in vitro data, we describe the effects of vitamin A related to gut immune tolerance/homeostasis, intestinal barrier integrity, and responses to enteropathogens in the context of the environmental enteric dysfunction. Some of the gaps in the literature that require further research are also highlighted.

6 April 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
JNJosé de Oliveira Vilar Neto
José de Oliveira Vilar Neto
WMWilson Max Almeida Monteiro De Moraes
Wilson Max Almeida Monteiro De Moraes
DPDaniel Pinto
Daniel Pinto
CSCarlos Alberto da Silva
Carlos Alberto da Silva
JCJuan de Sá Roriz Caminha
Juan de Sá Roriz Caminha
EDElizabeth De Francesco Daher
Elizabeth De Francesco Daher
Background: Tribulus terrestris L. Zygophyllaceae (TT) is a plant that has been claimed to increase testosterone levels and improve sexual function, particularly erectile dysfunction, with potential benefits for male sexual health. Purpose: This systematic review aimed to evaluate the effectiveness of TT supplementation in improving sexual function and serum testosterone levels in men. Methods: We conducted a systematic review adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. After searching the literature (n = 162), 52 studies were selected for full-text reading, and 10 studies were eligible for this review, comprising 9 clinical trials and 1 quasi-experimental study (a study without a control). The Jadad score revealed low methodological quality for 50% of the studies. Results: The studies involved 15 to 172 participants (total = 483) aged between 16 and 70 years with different health conditions: healthy men (n = 5), oligozoospermia (n = 1), erectile dysfunction (n = 1), erectile dysfunction associated with hypogonadism (n = 2), and unexplained infertility (n = 1). TT supplementation at doses of 400 to 750 mg/d for 1 to 3 months improved erectile dysfunction in 3 of the 5 studies that assessed this parameter. Eight out of ten studies did not report significant changes in androgen profile following TT supplementation, but the subjects in the neutral studies did not have low androgen levels at baseline. Therefore, only 2 studies showed significant intra-group increase in total testosterone levels, which had low clinical magnitude (60–70 ng/dL) and involved subjects with hypogonadism. Conclusions: TT supplementation has a low level of evidence regarding its effectiveness in improving erectile function in men with erectile dysfunction, and no robust evidence was found for increasing testosterone levels.

13 May 2020 in Toxicology Research
Verified
Journal Article
Closed access
PDF file
JNJosé de Oliveira Vilar Neto
José de Oliveira Vilar Neto
CSCarlos Alberto da Silva
Carlos Alberto da Silva
GMGdayllon Cavalcante Meneses
Gdayllon Cavalcante Meneses
DPDaniel Pinto
Daniel Pinto
LBLuciana Catunda Brito
Luciana Catunda Brito
EDElizabeth De Francesco Daher
Elizabeth De Francesco Daher
The aim of this study was to evaluate the impact of creatine supplementation (CS) on renal function in young, healthy, and active subjects. We used a randomized, double-blind, placebo-controlled clinical trial as the study design. Thirty-six healthy male university students were recruited and divided into three groups: group placebo, group G3 (3 g/day of CS), and group G5 (5 g/day of CS). To assess renal function, new kidney biomarkers, kidney injury molecule-1 (KIM-1) and monocyte chemoattractant protein-1 (MCP-1), were quantified. Serum albumin, serum creatinine, serum urea, estimated glomerular filtration rate (eGFR), proteinuria, and albuminuria were also measured. All groups were evaluated at two times: prior CS or placebo (pre) and after 35 days on CS or placebo (post). After 35 days of intervention, all characteristics were maintained without significant difference (P > 0.05) between the groups, including serum creatinine, eGFR, and more sensitive kidney biomarker concentrations (KIM-1 and MCP-1). The paired analysis showed that the supplemented groups (G3 and 5G) had increased serum creatinine and decreased eGFR levels (P < 0.05). However, the values were still within the normal reference range. In conclusion, the results of renal function evaluation did not show any difference between the evaluated groups. Increased serum creatinine and decreased eGFR levels in CS groups can be explained by increased creatine stores and metabolism, since creatinine is a by-product of creatine metabolism. These findings indicate that the use of CS at doses of 3 g and 5 g/day for a short period (35 days) is safe and did not impair the kidneys or renal function in young healthy subjects.

Verified
Journal Article
Open access
PDF file
TNTyciane S. Nascimento
Tyciane S. Nascimento
DPDaniel Pinto
Daniel Pinto
RDRonaldo P Dias
Ronaldo P Dias
RRRamon S. Raposo
Ramon S. Raposo
PNPaulo Iury Gomes Nunes
Paulo Iury Gomes Nunes
ROReinaldo Oria
Reinaldo Oria
Methylmercury (MeHg) is highly toxic to the human brain. Although much is known about MeHg neurotoxic effects, less is known about how chronic MeHg affects hippocampal amino acids and other neurochemical markers in adult mice. In this study, we evaluated the MeHg effects on systemic lipids and inflammation, hippocampal oxidative stress, amino acid levels, neuroinflammation, and behavior in adult male mice. Challenged mice received MeHg in drinking water (2 mg/L) for 30 days. We assessed weight gain, total plasma cholesterol (TC), triglycerides (TG), endotoxin, and TNF levels. Hippocampal myeloperoxidase (MPO), malondialdehyde (MDA), acetylcholinesterase (AChE), amino acid levels, and cytokine transcripts were evaluated. Mice underwent open field, object recognition, Y, and Barnes maze tests. MeHg-intoxicated mice had higher weight gain and increased the TG and TC plasma levels. Elevated circulating TNF and LPS confirmed systemic inflammation. Higher levels of MPO and MDA and a reduction in IL-4 transcripts were found in the hippocampus. MeHg-intoxication led to increased GABA and glycine, reduced hippocampal taurine levels, delayed acquisition in the Barnes maze, and poor locomotor activity. No significant changes were found in AChE activity and object recognition. Altogether, our findings highlight chronic MeHg-induced effects that may have long-term mental health consequences in prolonged exposed human populations.

30 July 2025 in Burns
Verified
Journal Article
Closed access
ACAna Paula Bomfim Soares Campelo
Ana Paula Bomfim Soares Campelo
EHErica Uchoa Holanda
Erica Uchoa Holanda
DPDaniel Pinto
Daniel Pinto
FSFlávia Almeida Santos
Flávia Almeida Santos
ROReinaldo Oria
Reinaldo Oria
PVPaulo Roberto Leitão de Vasconcelo
Paulo Roberto Leitão de Vasconcelo